Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease

Lade...
Vorschaubild
Dateien
2001_Wasem_Accumulation.pdf
2001_Wasem_Accumulation.pdfGröße: 365.05 KBDownloads: 725
Datum
2001
Autor:innen
Wasem, Christoph
Frutschi, Corina
Arnold, Diana
Vallan, Claudio
Lin, Tesu
Green, Douglas R.
Mueller, Christoph
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
ArXiv-ID
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Green
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Journal of Immunology. 2001, 167(5), pp. 2936-2941. ISSN 0022-1767. eISSN 1550-6606. Available under: doi: 10.4049/​jimmunol.167.5.2936
Zusammenfassung

Fas (CD95/APO-1) ligand (FasL)-mediated cytotoxicity has been implicated in tissue destruction in a variety of diseases, including acute graft-vs-host disease (GVHD). In this study, we have analyzed FasL expression and regulation during the course of experimental murine acute GVHD. Although activation-induced FasL-mediated cytotoxicity in control T cells was sensitive to the immunosuppressant cyclosporin A, we observed that functional FasL expression of GVHD T cells became increasingly cyclosporin A unresponsive. This was found to be the result of a massive in vivo accumulation and intracellular storage of FasL protein and its release in a transcription- and protein synthesis-independent manner. Immunohistochemistry analysis of FasL expression in situ revealed accumulation of FasL-expressing cells in the spleen, the liver, and small intestine, with a typical cytoplasmic and granular expression pattern. Thus, we conclude that the release of preformed FasL by infiltrating donor T cells may contribute to recipient tissue damage during the pathogenesis of acute GVHD.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690WASEM, Christoph, Corina FRUTSCHI, Diana ARNOLD, Claudio VALLAN, Tesu LIN, Douglas R. GREEN, Christoph MUELLER, Thomas BRUNNER, 2001. Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease. In: Journal of Immunology. 2001, 167(5), pp. 2936-2941. ISSN 0022-1767. eISSN 1550-6606. Available under: doi: 10.4049/​jimmunol.167.5.2936
BibTex
@article{Wasem2001Accum-14295,
  year={2001},
  doi={10.4049/​jimmunol.167.5.2936},
  title={Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease},
  number={5},
  volume={167},
  issn={0022-1767},
  journal={Journal of Immunology},
  pages={2936--2941},
  author={Wasem, Christoph and Frutschi, Corina and Arnold, Diana and Vallan, Claudio and Lin, Tesu and Green, Douglas R. and Mueller, Christoph and Brunner, Thomas}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/14295">
    <dc:contributor>Lin, Tesu</dc:contributor>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/14295"/>
    <dc:creator>Arnold, Diana</dc:creator>
    <dc:creator>Vallan, Claudio</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Wasem, Christoph</dc:creator>
    <dc:contributor>Arnold, Diana</dc:contributor>
    <dc:creator>Frutschi, Corina</dc:creator>
    <dc:contributor>Green, Douglas R.</dc:contributor>
    <dc:contributor>Frutschi, Corina</dc:contributor>
    <dc:creator>Mueller, Christoph</dc:creator>
    <dc:language>eng</dc:language>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/14295/2/2001_Wasem_Accumulation.pdf"/>
    <dcterms:abstract xml:lang="eng">Fas (CD95/APO-1) ligand (FasL)-mediated cytotoxicity has been implicated in tissue destruction in a variety of diseases, including acute graft-vs-host disease (GVHD). In this study, we have analyzed FasL expression and regulation during the course of experimental murine acute GVHD. Although activation-induced FasL-mediated cytotoxicity in control T cells was sensitive to the immunosuppressant cyclosporin A, we observed that functional FasL expression of GVHD T cells became increasingly cyclosporin A unresponsive. This was found to be the result of a massive in vivo accumulation and intracellular storage of FasL protein and its release in a transcription- and protein synthesis-independent manner. Immunohistochemistry analysis of FasL expression in situ revealed accumulation of FasL-expressing cells in the spleen, the liver, and small intestine, with a typical cytoplasmic and granular expression pattern. Thus, we conclude that the release of preformed FasL by infiltrating donor T cells may contribute to recipient tissue damage during the pathogenesis of acute GVHD.</dcterms:abstract>
    <dc:creator>Lin, Tesu</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/14295/2/2001_Wasem_Accumulation.pdf"/>
    <dc:contributor>Mueller, Christoph</dc:contributor>
    <dc:creator>Brunner, Thomas</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-10-21T12:42:22Z</dcterms:available>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-10-21T12:42:22Z</dc:date>
    <dcterms:title>Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease</dcterms:title>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:contributor>Vallan, Claudio</dc:contributor>
    <dc:creator>Green, Douglas R.</dc:creator>
    <dc:contributor>Wasem, Christoph</dc:contributor>
    <dcterms:bibliographicCitation>First publ. in: Journal of Immunology ; 167 (2001), 5. - S. 2936-2941</dcterms:bibliographicCitation>
    <dc:rights>terms-of-use</dc:rights>
    <dc:contributor>Brunner, Thomas</dc:contributor>
    <dcterms:issued>2001</dcterms:issued>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
Begutachtet
Diese Publikation teilen